Research and experimental development on natural sciences and engineering
ABLY MEDICAL AS
Revenue 2024
NOK 18.3m
Operating profit
NOK −3.1m
Equity
NOK 87.9m
Incorporated
2015
Employees
9
Share capital
NOK 302,000
Key figures · 2024
Current ratio
2.03
Equity ratio
88.0%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -17.0% | |
| Net margin (%%) | -16.8% | |
| Return on assets (%%) | -3.1% | |
| Likviditet | ||
| Current ratio | 2.03 | |
| Working capital | 9.2m | |
| Soliditet | ||
| Equity ratio (%%) | 88.0% | |
| Debt-to-equity ratio | 0.14 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.